Company news
Sharp Therapeutics Corp. news in 2025
Sharp Therapeutics Corp.'s news releases, calls and decks from 2025, newest first.
Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options
December 19, 2025
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
Sharp Therapeutics Arranges Non-Brokered Private Placement
October 14, 2025
Sharp Therapeutics to Present Pipeline and Program Updates at World Orphan Drug Congress 2025
October 8, 2025
Sharp Therapeutics Corp. Reports Second Quarter 2025 Results and Expands Market Presence with Listing On OTCQB
August 29, 2025
Sharp Therapeutics Corp. Engages Rho Inc. to Help Advance Compounds into Clinical Trials for Gaucher Disease
July 29, 2025
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
July 21, 2025
Sharp Therapeutics Corp. Reports First Quarter 2025 Results
May 22, 2025
Sharp Therapeutics Corp. Nominates Clinical Candidate for Gaucher's Disease
May 13, 2025
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
Sharp Therapeutics Corp. Completes Share Consolidation
January 27, 2025
Sharp Therapeutics Corp. Announces Share Consolidation
January 16, 2025